Application no. and date | 13173895.7 (espacenet) (Federated) (European Patent Register), 20070122 | Patent/reg. no. and date | DK/EP 2666476, 20181219 | Publication date | 20131127 | Priority no. and date | US 760378 P, 20060120 | EP pub. no. and date |
EP 2666476 20131127 | Effective date | | Applicant/owner | Genzyme Corporation, 50 Binney Street
Cambridge, MA 02142, US | Applicant ref. no. | SAN 15979-20096.46 | Inventor | DODGE, James, Genzyme Corporation 15 Pleasant Street
Framingham, MA 01701-9322, US, PASSINI, Marco, Genzyme Corporation 15 Pleasant Street
Framingham, MA 01701-9322, US, SHIHABUDDIN, Lamya, Genzyme Corporation 15 Pleasant Street
Framingham, MA 01701-9322, US, CHENG, Seng, Genzyme Corporation 15 Pleasant Street
Framingham, MA 01701-9322, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 38/46 (2006.01) | Title | Intraventrikulær enzymadministration ved lysosomale aflejringssygdomme | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|